Direct supply line allocations from our primary manufacturing unit. High-precision active compounds and reference standards complete with multi-spectrum COA validation.
A comprehensive examination of structural parameters, industrial route selection, continuous crystallization, and compliance validation for institutional enterprise buyers.
The chemical entity designated by CAS 434-07-1 represents a critical steroidal scaffold and pharmaceutical intermediate with demanding molecular purity profiles. Operating under molecular formula C21H32O3 and a molecular weight of 332.48 g/mol, the synthesis of this target substrate necessitates rigid stereochemical control across multi-step cyclization, selective oxidation, and reduction sequences. Enterprise pharmaceutical researchers and downstream formulators cannot afford batch variabilities, unreacted steroid precursors, or isomeric impurities that jeopardize clinical and pre-clinical trials.
Hebei Miaoou Technology Co., Ltd. (operating advanced synthesis clusters in Hebei, China since 2010) has refined the industrial preparation of CAS 434-07-1 through multi-stage preparative crystallization and catalytic hydrogenation loops. By establishing real-time in-line spectroscopic process monitoring (PAT), our industrial chemical park maintains an exceptional isomeric excess, minimizing residual metals to low single-digit PPM levels and reducing total organic volatile impurities well below stringent ICH Q3C limits.
| Analytical Metric | Methodology / Instrumentation | Industrial Quality Limit | Certified Factory Typical Batch |
|---|---|---|---|
| Identity (Fingerprinting) | FTIR / 1H-NMR / 13C-NMR | Conforms to Primary Reference Standard | Conforms (Exact Match) |
| Assay Purity (Dry Basis) | HPLC-UV (Agilent 1260 Infinity II) | ≥ 98.50% w/w | 99.35% w/w |
| Individual Unknown Impurity | Reversed-Phase Gradient HPLC | ≤ 0.10% a/a | < 0.04% a/a |
| Loss on Drying (LOD) | Vacuum Desiccation @ 105°C | ≤ 0.50% w/w | 0.18% w/w |
| Heavy Metals (Pb, As, Cd, Hg) | ICP-MS (Inductively Coupled Plasma) | ≤ 10 ppm Total | < 2.5 ppm Total |
| Specific Optical Rotation | Polarimetry (Sodium D Line, 20°C) | +34.0° to +38.0° (c=1 in dioxane) | +36.2° |
Why Tier-1 institutional buyers and pharmaceutical laboratories leverage Chinese direct synthesis infrastructure for structural steroid precursors and intermediates.
Unlike secondary chemical brokers or repacking outfits, our facility in Shijiazhuang, Hebei controls the upstream steroidal nucleus supply line. By synthesizing core intermediates from sustainably sourced phytosterols through multi-step bio-fermentation and chemical conversion, we mitigate raw material price surges and secure an uninterrupted production volume year-round.
Our computerized jacketed glass-lined and hastelloy reactor systems range from 500L pilot setups to 5,000L industrial continuous-feed vessels. This industrial consolidation achieves notable thermal efficiency, high atom economy, and lower waste-stream overheads, allowing global partners to acquire CAS 434-07-1 with a distinct price-to-purity margin.
Modern Chinese chemical manufacturing is grounded in rigid environmental governance. Our facility is equipped with dedicated regenerative thermal oxidizers (RTO) for VOC eradication and zero-liquid-discharge (ZLD) wastewater reclamation circuits, guaranteeing long-term regulatory compliance and preventing unexpected state-mandated plant shutdowns.
Mapping the transition from obsolete supply chains toward high-transparency, analytics-driven fine chemical procurement architectures.
Global procurement teams across North America and Europe no longer rely on simple one-page COAs. Current vendor qualification demands accessible raw analytical files, including full HPLC retention profiles, expanded UV absorption traces, and high-resolution LC-MS/MS parent ion fragmentation data to eliminate counterfeit or adulterated batches.
Geopolitical friction and logistical choke points have triggered a shift toward hybrid holding strategies. Leading international laboratories partner directly with primary manufacturing hubs in Hebei while establishing rapid replenishment buffers via domestic holding warehouses, ensuring transit times drop from weeks to within 72 hours.
As biological and analytical screening assays become increasingly sensitive, minor impurities that once went unnoticed now trigger false positives in cellular proliferation and hormonal binding tests. Modern buyers prioritize producers capable of validating related substances below 0.05% with zero residual heavy metal catalysts.
Technical evaluation of downstream translational workflows for CAS 434-07-1 across qualified scientific disciplines.
Employed by government, academic, and anti-doping reference laboratories for calibration curves in gas chromatography-mass spectrometry (GC-MS) and LC-MS metabolomics assays.
Utilized as an in-vitro biochemical probe for assessing androgen receptor binding kinetics, transcriptional activation cofactors, and myotrophic-to-androgenic dissociation indexes.
Acts as an adaptable precursor for the introduction of unique stereospecific side-chains, isotopic labeling (Deuterium/C13), and fluorinated derivatives in medicinal chemistry programs.
Investigated in pre-clinical rodent cell lines to dissect cellular protein accretion dynamics, nitrogen retention efficiency, and satellite cell activation cascades under controlled conditions.
Eliminating customs holdups, transit degradation, and documentation mismatches through standardized protocols.
Cross-border fine chemical transactions often encounter border holds due to discordant labeling or missing regulatory declarations. Hebei Miaoou Technology Co., Ltd. resolves regulatory bottlenecks via an automated documentation suite generated at every batch release:
We operate direct freight corridors via air cargo from major logistical hubs (Beijing, Shanghai, Hong Kong) alongside regional multi-point fulfillment centers.
• Average EU/UK Transit: 4–7 business days via priority insured couriers.
• Average North American Transit: 3–5 business days via domestic forwarding hub.
• Packaging Format: High-barrier vacuum foil bags, HDPE drums, or customized amber vial sets with nitrogen flushing to safeguard against oxidative degradation.
Supplementary core raw materials, active peptides, and therapeutic reference compounds manufactured in our certified cleanrooms.
Essential guidance addressing regulatory scope, testing procedures, minimum order quantities, and enterprise partnership safeguards.
Our standard industrial grade conforms strictly to ≥99.0% total purity by reversed-phase high-performance liquid chromatography (RP-HPLC). Ultra-purified reference grade lots exceeding 99.5% are prepared via secondary preparative crystallization upon explicit client commission.
Every batch undergoes rigorous orthogonal testing. This integrates high-field 1H and 13C Nuclear Magnetic Resonance (NMR) spectroscopy to confirm the 5α-androstane stereochemical orientation, alongside high-resolution mass spectrometry (HRMS) verifying exact isotopic mass at 332.48 Da.
Yes. We support pre-shipment sample dispatch (1g to 5g sealed analytical vials) directly to your designated CRO, domestic university laboratory, or third-party inspection agency (e.g., SGS). Industrial orders can be escrowed or linked to analytical sign-off.
We accommodate pilot testing starting from 100 grams up to multi-metric ton long-term supply contracts. Standard warehouse inventory ships within 24 to 48 hours; custom large-scale continuous synthesis runs require a lead time of 10 to 14 business days.
The material is dried under deep vacuum to eliminate residual hydration, flushed with inert dry nitrogen gas, and triple-sealed into light-impermeable medical-grade aluminum vacuum foil bags, then packaged inside fiber drums with desiccants to completely prevent photolytic or hydrolytic cleavage.
All materials detailed on this portal are sold strictly for in-vitro research, standard analytical testing, and non-medicinal chemical development by licensed laboratories. They are not intended for human consumption, veterinary medication, cosmetic compounding, or direct therapeutic intervention.